the phylogenetic and taxonomical finding on February 11, the coronavirus (COV) study group (CGS) of the International Committee on Virus Taxonomy (ICTV) designated the virus as SARS-CoV-2. [1] The same day, the director general of the World Health Organization (WHO) designated the disease caused by SARS-CoV-2 "coronavirus disease 2019" (COVID-19). The WHO declared COVID-19 a pandemic On March 11, 2020. Globally as of June 2021, 179 686 071 confirmed cases of COVID-19, including 3 899 172 deaths, reported by WHO. [2] Reducing the burden of COVID-19 infection by developing vaccines and antiviral drugs is still a big challenge for researchers and clinicians.Nowadays, nanotechnology is a promising player in the scientific and medical fields with many applications. [3,4] A new dimension has been opened by the functionally tunable nanosized materials for industrial, biomedical, and scientific purposes, which provides a set of techniques that allow the manipulation of structural and functional properties on a microscale. [5,6] Nanotechnology is kindred with the biomedicinal involvement of nanoparticles (NPs), which are not only used as the backbone in the vaccine to formulate "nanovaccines," nanomaterial-based antiviral agents, disinfectants; which inhibit the multiplication within the host or inactivate them outside the host, but also the application of designed nanorobots to detect and repairs of tissue defects at the cellular level. [7,8] Unlike the conventional drug formulations, which typically circulate throughout the entire body parts, nanoparticles may target a desired part of the body as a targeted drug delivery vehicle. Compared to conventional vaccines, nanovaccines or surface-functionalized nanoparticles can be designed, explicitly targeting lymphatic organs and immune cells to provoke better immune responses. Moreover, the localized infections are challenging to be treated by the conventional vaccines but can be treated by the nanovaccines with specific cells or organ-targeting molecules. In some cases, the nanobased settings are applied to enhance the solubility of hydrophobic compounds. These systems are helpful to protect the antigens from degradation and stabilize a large number of therapeutic biomolecules, such as peptides, proteins, and nucleic acids on the substrate. [9] Viral infections, particularly COVID-19, have posed a severe threat to public health globally because of their wide-sphered distribution and their potent ability to change the genetic makeup. [10] Unfortunately, viruses have adopted various alternative tacticsThe COVID-19 infections have posed an unprecedented global health emergency, with nearly three million deaths to date, and have caused substantial economic loss globally. Hence, an urgent exploration of effective and safe diagnostic/therapeutic approaches for minimizing the threat of this highly pathogenic coronavirus infection is needed. As an alternative to conventional diagnosis and antiviral agents, nanomaterials have a great potential to cope with the current or even futu...